Contineum Therapeutics Overview
Contineum Therapeutics Discounted Cash Flow
DCF Analysis for CTNM.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.43
Current Fair Value
$2.43
↓ 79.5% Downside
Overvalued by 79.5% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison